Journal of Alcoholism & Drug Dependence

Journal of Alcoholism & Drug Dependence
Open Access

ISSN: 2329-6488

+44 1202068036

Citations Report

Citations Report - Journal of Alcoholism & Drug Dependence [718 Articles]

The articles published in Journal of Alcoholism & Drug Dependence have been cited 718 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Alcoholism & Drug Dependence.

Ezard N, Hodge S, Dolan K (2015) The development and evaluation of stimulant treatment programmes. Current opinion in psychiatry 28(4): 280-285.

Shukla P, Tyagi N (2015) Alzheimer’s disease: A Common Form of Neurodegeneration. Research and Reviews: Journal of Medical and Health Sciences.

Caetano R, Vaeth PA, Mills BA. Rates and predictors of DUI among US–Mexico border and non-border Mexican Americans. Accident Analysis & Prevention. 2013; 59: 289-295.

Patkar OL, Belmer A, Bartlett SE. Contribution of Noradrenaline, Serotonin, and the Basolateral Amygdala to Alcohol Addiction: Implications for Novel Pharmacotherapies for AUDs. Recent Advances in Drug Addiction Research and Clinical Applications. 2016; 14:115.

Allenby C, Falcone M. Using Genetics to Improve Addiction Treatment Outcomes. Current Behavioral Neuroscience Reports. 2017 Mar 1;4(1):1-9.

Bress A, Kittles R, Wing C, Hooker Jr SE, King A. Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenetics and genomics. 2015; 25(6):305.

Helton SG, Lohoff FW. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry research. 2015; 230(2):121-129.

Ragia G, Manolopoulos VG. Pharmacogenomics of alcohol addiction: personalizing pharmacologic treatment of alcohol dependence. Hospital Pharmacology-International Multidisciplinary Journal. 2014;1(3):147-167.

Sun Y, Zhang Y, Wang F, Sun Y, Shi J, et al. (2016) From genetic studies to precision medicine in alcohol dependence. Behavioural pharmacology 27(2 and 3-Special Issue): 87-99.

Chen, A.C., Davis, C.M., Kahler, C.W., Kuerbis, A.N., Covault, J., Kranzler, H.R. and Morgenstern, J. 5‐HTTLPR Moderates Naltrexone and Psychosocial Treatment Responses in Heavy Drinking Men Who Have Sex with Men. Alcoholism: Clinical and Experimental Research. 2014;38(9): 2362-2368.

Jonas DE, Amick HR, Feltner C, Wines R, Shanahan E, Rowe CJ, Garbutt JC. Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis. Pharmacogenomics. 2014; 15(13: 1687-700.

Jones JD, Comer SD, Kranzler HR. The pharmacogenetics of alcohol use disorder. Alcoholism: Clinical and Experimental Research. 2015; 39(3):391-402.

Demers CH, Bogdan R, Agrawal A. The genetics, neurogenetics and pharmacogenetics of addiction. Current behavioral neuroscience reports. 2014 1;1(1):33-44.

Hall KT, Loscalzo J, Kaptchuk TJ. Genetics and the placebo effect: the placebome. Trends in molecular medicine. 2015; 21(5):285-294.

Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern?. CNS drugs. 2014; 28: 491-496.

YEŞİL B, ELBOZAN HB. Gabapentin withdrawal in a depressed patient: A case report. Anatolian Journal of Psychiatry/Anadolu Psikiyatri Dergisi. 2016; 2: 17.


Chiappini S, Schifano F. A decade of gabapentinoid misuse: an analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ database. CNS drugs. 2016;30:647-654.

Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern?. CNS drugs. 2014;28: 491-496.

Davidson C, Schifano F (2016) The potential utility of some legal highs in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64: 267-274.

Relevant Topics